فرشاة غسيل سيارات أوتوماتيكية دوارة بزاوية 360 درجة
وفر 9%! اشترِ فرشاة غسيل سيارات أوتوماتيكية دوارة بزاوية 360 درجة بسعر 274.95 د.
🛒 تسوق الآنLibyan Study Reveals Antibiotic Resistance Genes in Misurata ICU Patients
Libyan Study Reveals Antibiotic Resistance Genes in Misurata ICU Patients
Carbapenem-Resistant Bacteria Detected in Libyan Hospital ICU
A new study published in the AlQalam Journal of Medical and Applied Sciences has uncovered alarming rates of metallo-β-lactamase gene presence among Pseudomonas aeruginosa isolates from Intensive Care Unit patients at a Misurata hospital. The findings highlight a growing antimicrobial resistance crisis demanding urgent attention across Libya's healthcare system.
Researchers identified MBL-producing genes through both phenotypic and molecular methods, confirming that a significant proportion of isolates carried genes encoding carbapenem resistance — one of the last-resort antibiotic classes for treating severe bacterial infections.
What Are Metallo-β-Lactamase Genes and Why Do They Matter?
Metallo-β-lactamases are enzymes produced by bacteria that break down carbapenem antibiotics, rendering them ineffective. Carbapenems are the most powerful β-lactam agents, reserved for life-threatening infections where other drugs fail. When bacteria acquire MBL genes, they become resistant to nearly all available β-lactam treatments.
The World Health Organization classifies carbapenem-resistant P. aeruginosa as a priority 1 critical pathogen — the highest antimicrobial resistance threat level globally. In Libya, where healthcare infrastructure has been strained by years of instability, these resistance patterns pose severe clinical challenges.
Dual Detection Approach Strengthens Findings
The research team employed a two-pronged detection strategy:
- Phenotypic methods: Combined disc tests and modified Hodge tests screened for MBL production — a cost-effective approach suitable for resource-limited laboratories.
- Molecular methods: Polymerase chain reaction confirmed specific MBL-encoding genes, providing definitive genetic evidence of resistance mechanisms.
This dual approach is particularly relevant for Libyan hospitals. A 2025 study in the Journal of Microbiological Methods noted that practical phenotypic methods can support routine screening in laboratories lacking expensive molecular tools — a common reality in Libya's under-resourced facilities.
Resistance Profiles Paint a Concerning Picture
Beyond MBL detection, the study mapped complete antimicrobial resistance profiles. Results revealed multi-drug resistance patterns, with many isolates resistant to three or more antibiotic classes simultaneously. This severely limits treatment options for infected ICU patients, who are already among the most vulnerable in any hospital.
ICU patients face elevated infection risks from invasive devices, prolonged hospitalization, and weakened immunity. When infecting bacteria carry MBL genes, clinicians must turn to combination therapies or newer, costlier drugs — many unavailable in Libyan pharmacies.
Libya's Antibiotic Challenge in Regional Context
Libya is not alone in facing this threat. Across North Africa and the Middle East, MBL-producing P. aeruginosa has been documented with increasing frequency. However, Libya's situation is compounded by limited laboratory capacity for molecular surveillance, disrupted pharmaceutical supply chains, insufficient national antimicrobial stewardship, and self-medication practices driven by unregulated antibiotic sales.
Why This Research Matters for Libyan Public Health
This study represents a critical contribution to Libya's infectious disease surveillance. By documenting MBL prevalence in Misurata's ICU, researchers provide baseline data essential for designing targeted infection control protocols, informing national antibiotic policy, guiding empirical therapy choices, and attracting international collaboration for antimicrobial resistance research in Libya.
The AlQalam Journal, published by the University of Tripoli, continues to serve as a vital platform for Libyan medical research. Studies like this demonstrate that Libyan scientists are producing globally relevant work on one of the century's most pressing health threats.
— Libya Press / Health Desk
